You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Trivariate Research
since
auto-detected in 11 stories
5 days ago
With dividend yields not what they once were, investors should be choosing investments wisely in order to maximize returns, according to Trivariate Research.
20 days ago
This industry group is the star of 2026, besides energy. Trivariate says these stocks are a buy ⊕
Here's where the cohort can go after posting its best start to the year in a quarter century, according to Trivariate Research.
4 months ago
The dividend yield on the S&P 500 is the lowest since the dotcom bubble ⊖
The yield on the S&P 500 is at 1.15%. The only time it sank lower was during the tech bubble, Trivariate Research said.
7 months ago
Buy stock 'compounders' for the long-term and tune out any near-term noise, Trivariate Research says ○
The research firm highlighted nearly two dozen companies that are forecast to continue boosting gross margins in the quarters ahead.
9 months ago
Play defense with these dividend-paying stocks, says Trivariate Research's Adam Parker ○
Trivariate Research found several companies with consistent dividend growth that it says are poised to outperform.
10 months ago
Wall Street's rebound puts pressure on earnings to justify high stock prices ○
The risk-reward for the S&P 500 is "not particularly attractive," said Trivariate Research founder Adam Parker.
11 months ago
Top strategist Parker is more negative now than two weeks ago after market comeback ○
Investors who believe the worst of the tariff news has been priced into the market may be celebrating prematurely, said Trivariate Research's Adam Parker.
These stocks are historically cheap after tariff-driven sell-off, Trivariate finds ○
For investors looking for a bargain, there is a group of stocks that are cheap relative to their respective historical trends, according to Trivariate Research.
13 months ago
Low-beta growth stocks to ride out the Trump roller coaster, according to Trivariate Research ○
found
Buying low-beta stocks such as Mastercard and Boston Scientific could help improve portfolio performance, Trivariate Research said.
14 months ago
Wall Street is souring on 'Magnificent 7' stocks after group's worst earnings season since 2022 ○
Now is a 'prudent' time for investors to consider lowering their exposure to the 'Magnificent 7' cohort, Trivariate Research wrote in a recent note.